TSHA Taysha Gene Therapies, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 11, 2026
$4,63
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$3,69rendah 52m
$7,30tinggi 52m
Kapitalisasi Pasar (MRQ)
$1.51B
P/E (TTM)
-11.0
EPS (TTM)
$-0.42
Pendapatan (TTM)
$5M
lencana Anda
Rentang 52M
$4–$7
Peringkat Analis
BUY
Target Harga
$13
P/E
-11.0
ROE
-47.1%
Margin Laba Bersih
-2728.0%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
TSHA Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.63
Kapitalisasi Pasar (MRQ)
$1.51B
P/E (TTM)
-11.0
EPS (TTM)
$-0.42
Pendapatan (TTM)
$5M
ROE (TTM)
-47.1%
D/E Utang/Ekuitas (MRQ)
0.1
Rentang 52M
$4–$7
TSHA Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$10M2022-12-31 → 2025-12-31
EPS$-0.342021-12-31 → 2025-12-31
Arus Kas Bebas$-94M2020-12-31 → 2025-12-31
Margin bersih-2728.0%2023-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | TSHA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E (TTM) | -11.0rata-rata 5T ≈-5.2 | ≈-5.2 | · | · | |
| P/S (TTM) | 274.6rata-rata 5T ≈74.8 | ≈74.8 | 30.8 | Terlalu mahal | |
| P/B (MRQ) | 3.9rata-rata 5T ≈5.1 | ≈5.1 | 5.8 | Nilai wajar | |
| EV / EBITDA | -9.6rata-rata 5T ≈-4.9 | ≈-4.9 | · | · | |
| Harga / FCF (TTM) | -11.4rata-rata 5T ≈-7.2 | ≈-7.2 | · | · | |
| Harga / Arus Kas (TTM) | -11.4rata-rata 5T ≈-7.4 | ≈-7.4 | · | · | |
| EV / Revenue (EV / Pendapatan) | 108.5rata-rata 5T ≈59.6 | ≈59.6 | · | · | |
| EV / FCF | -11.3rata-rata 5T ≈-5.6 | ≈-5.6 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 5.4rata-rata 5T ≈34.2 | ≈34.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | TSHA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Margin Operasi (TTM) | -2792.3%rata-rata 5T ≈-899.0% | ≈-899.0% | -418.6% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -1130.7%rata-rata 5T ≈-899.0% | ≈-899.0% | -418.3% | Lemah | |
| Margin Laba Bersih (TTM) | -2728.0%rata-rata 5T ≈-969.7% | ≈-969.7% | -433.8% | Lemah | |
| ROA (TTM) | -37.2%rata-rata 5T ≈-61.3% | ≈-61.3% | -37.1% | Lemah | |
| ROE (TTM) | -47.1%rata-rata 5T ≈-291.9% | ≈-291.9% | -42.7% | Lemah |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | TSHA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Utang / Ekuitas (MRQ) | 0.1rata-rata 5T ≈0.4 | ≈0.4 | 0.1 | Sejajar | |
| Rasio Lancar (MRQ) | 17.8rata-rata 5T ≈6.2 | ≈6.2 | 7.2 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 12.0rata-rata 5T ≈6.0 | ≈6.0 | 4.3 | Likuiditas kuat | |
| Utang Jangka Panjang / Ekuitas (MRQ) | 0.1rata-rata 5T ≈0.4 | ≈0.4 | · | · |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | TSHA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | 17.3%rata-rata 5T ≈162.9% | ≈162.9% | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | 57.5% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | TSHA | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.1 | ≈0.1 | 0.3 | Lemah | |
| Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.) | ≈$98.7K | · | · | · |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
0.53%
Laporan Berikutnya
Nov 02, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 17, 2026 | $-0.14 | $-0.12 | -17.7% |
| 31 Maret 2026 | Mei 20, 2026 | $-0.12 | $-0.10 | -20.5% |
| 31 Des. 2025 | $-0.08 | $-0.10 | 18.5% | |
| 30 Sep. 2025 | $-0.09 | $-0.09 | 0.00% | |
| 30 Juni 2025 | $-0.09 | $-0.08 | -9.1% | |
| 31 Maret 2025 | $-0.08 | $-0.09 | 15.3% | |
| 31 Des. 2024 | $-0.07 | $-0.08 | 17.4% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $10M | $8M | $15M | $3M | |
| R&D Expense | $86M | $66M | $57M | $91M | |
| SG&A Expense | $34M | $29M | $30M | $37M | |
| Operating Expenses | $120M | $100M | $88M | $165M | |
| Operating Income | $-110M | $-91M | $-72M | $-162M | |
| Interest Expense | · | · | $5M | $4M | |
| Interest Income | $9M | $7M | $4M | · | |
| Other Non-op | $-291.0K | $-110.0K | $-47.0K | $-18.0K | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-109M | $-89M | $-112M | $-166M | |
| EPS (Basic) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| EPS (Diluted) | $-0.34 | $-0.36 | $-0.96 | $-3.78 | |
| Shares (Basic) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| Shares (Diluted) | 319,711,972 | 250,134,421 | 116,121,482 | 43,952,015 | |
| EBITDA | $-110M | $-91M | $-72M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $320M | $139M | $144M | $88M | |
| Prepaid Expense | $4M | $3M | $3M | $9M | |
| Other Current Assets | $802.0K | $308.0K | $292.0K | $466.0K | |
| Current Assets | $325M | $142M | $150M | $96M | |
| PP&E (Net) | $7M | $7M | $11M | $15M | |
| PP&E (Gross) | $11M | $11M | $14M | $17M | |
| Accum. Depreciation | $5M | $4M | $3M | $2M | |
| Other Non-current Assets | $183.0K | $217.0K | $304.0K | $1M | |
| Total Assets | $343M | $160M | $173M | $126M | |
| Accounts Payable | $6M | $4M | $6M | $11M | |
| Current Liabilities | $27M | $26M | $37M | $63M | |
| Capital Leases | $18M | $17M | $19M | $20M | |
| Other Non-current Liabilities | $2M | $1M | $2M | $4M | |
| Total Liabilities | $96M | $89M | $98M | $125M | |
| Long-term Debt | · | · | · | $38M | |
| Total Debt | $50M | $44M | $41M | · | |
| Common Stock | $3.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $958M | $678M | $588M | $402M | |
| Retained Earnings | $-711M | $-602M | $-513M | $-401M | |
| AOCI | $-192.0K | $-4M | · | · | |
| Stockholders' Equity | $247M | $72M | $75M | $949.0K | |
| Liabilities + Equity | $343M | $160M | $173M | $126M | |
| Shares Outstanding | 285,051,648 | 204,943,306 | 186,960,193 | 63,207,507 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $13M | $13M | $8M | $18M | |
| Operating Cash Flow | $-93M | $-81M | $-73M | $-88M | |
| CapEx | $738.0K | $374.0K | $4M | $21M | |
| Investing Cash Flow | $-604.0K | $-363.0K | $-7M | $-25M | |
| Stock Issued | · | · | $500.0K | · | |
| Financing Cash Flow | $275M | $77M | $136M | $52M | |
| Net Change in Cash | $181M | $-5M | $56M | $-61M | |
| Free Cash Flow | $-94M | $-82M | $-77M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -1130.7% | -1097.5% | -468.8% | · | |
| Net Margin | -1115.3% | -1071.6% | -722.1% | · | |
| EBITDA Margin | -1130.7% | -1097.5% | -468.8% | · | |
| ROA | -43.3% | -53.6% | -74.6% | · | |
| ROE | -44.0% | -111.4% | -864.1% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 12.2 | 5.4 | 4.1 | · | |
| Quick Ratio | 12.0 | 5.3 | 3.9 | · | |
| Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| LT Debt / Equity | 0.2 | 0.6 | 0.5 | · | |
| Interest Coverage | · | · | -14.5 | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Book Value / Share | $0.87 | $0.35 | $0.40 | · | |
| Revenue / Share | $0.03 | $0.03 | $0.13 | · | |
| Cash Flow / Share | $-0.29 | $-0.32 | $-0.63 | · | |
| Cash / Share | $1.12 | $0.68 | $0.77 | · | |
| EPS (TTM) | $-0.34 | $-0.36 | $-0.96 | $-3.78 |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 17.3% | -46.1% | 517.6% | · | |
| Revenue CAGR 3Y | 57.5% | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $10M | $8M | $15M | $3M | |
| Net Income TTM | $-109M | $-89M | $-112M | $-166M | |
| Market Cap | $1.57B | $355M | $331M | · | |
| Enterprise Value | $1.30B | $259M | $227M | · | |
| P/E | -16.2 | -4.8 | -1.8 | -0.6 | |
| P/S | 160.4 | 42.5 | 21.4 | · | |
| P/B | 6.3 | 5.0 | 4.4 | · | |
| P / Tangible Book | 6.3 | 5.0 | 4.4 | 150.5 | |
| P / Cash Flow | -16.8 | -4.4 | -4.5 | · | |
| P / FCF | -16.7 | -4.3 | -4.3 | · | |
| EV / EBITDA | -11.7 | -2.8 | -3.1 | · | |
| EV / FCF | -13.8 | -3.2 | -3.0 | · | |
| EV / Revenue | 132.8 | 31.1 | 14.7 | · | |
| Earnings Yield | -6.2% | -20.8% | -54.2% | -167.3% |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $5M | $0 | $2M | $2M | $2M | $2M | $1M | $3M | $4M | $5M | $2M | $5M | |
| R&D Expense | $39M | $34M | $25M | $26M | $20M | $16M | $15M | $15M | $15M | $21M | $13M | $12M | $20M | $13M | |
| SG&A Expense | $12M | $10M | $9M | $8M | $9M | $8M | $7M | $8M | $7M | $7M | $7M | $9M | $6M | $9M | |
| Operating Expenses | $47M | $43M | $34M | $34M | $29M | $24M | $22M | $28M | $22M | $28M | $20M | $21M | $26M | $21M | |
| Operating Income | $-47M | $-43M | $-28M | $-34M | $-27M | $-21M | $-20M | $-26M | $-21M | $-24M | $-16M | $-16M | $-23M | $-17M | |
| Interest Expense | · | · | · | · | · | · | · | · | $27.0K | $29.0K | · | $1M | $1M | $1M | |
| Interest Income | $2M | $3M | $3M | $3M | $2M | $1M | $2M | $2M | $1M | $2M | $2M | $1M | · | · | |
| Other Non-op | $-88.0K | $-31.0K | $-30.0K | $-37.0K | $-237.0K | $13.0K | $-66.0K | $-81.0K | $42.0K | $-5.0K | $-23.0K | $-19.0K | $3.0K | $-8.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | |
| Net Income | $-47M | $-42M | $-28M | $-33M | $-27M | $-22M | $-19M | $-26M | $-21M | $-24M | $48M | $-117M | $-25M | $-18M | |
| EPS (Basic) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| EPS (Diluted) | $-0.13 | $-0.12 | $-0.08 | $-0.09 | $-0.09 | $-0.08 | $-0.07 | $-0.10 | $-0.09 | $-0.10 | $0.63 | $-0.93 | $-0.38 | $-0.28 | |
| Shares (Basic) | 369,044,040 | 366,632,827 | · | 353,309,524 | 297,988,978 | 269,306,331 | · | 267,824,045 | 232,821,553 | 231,249,344 | · | 125,700,799 | 64,244,531 | 63,260,905 | |
| Shares (Diluted) | 369,044,040 | 366,632,827 | · | 353,309,524 | 297,988,978 | 269,306,331 | · | 267,824,045 | 232,821,553 | 231,249,344 | · | 125,700,799 | 64,244,531 | 63,260,905 | |
| EBITDA | $-47M | $-43M | · | $-34M | $-27M | $-21M | · | $-26M | $-21M | $-24M | · | $-16M | $-23M | $-17M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $455M | $277M | $320M | $297M | $313M | $117M | $139M | $158M | $173M | $124M | $144M | $164M | $45M | $63M | |
| Prepaid Expense | $6M | $5M | $4M | $2M | $3M | $4M | $3M | $3M | $3M | $4M | $3M | $6M | $9M | $9M | |
| Other Current Assets | $851.0K | $1M | $802.0K | $456.0K | $657.0K | $536.0K | $308.0K | $465.0K | $206.0K | $149.0K | $292.0K | $404.0K | $510.0K | $532.0K | |
| Current Assets | $461M | $282M | $325M | $300M | $316M | $121M | $142M | $162M | $178M | $131M | $150M | $172M | $54M | $72M | |
| PP&E (Net) | $2M | $6M | $7M | $7M | $7M | $7M | $7M | $8M | $11M | $11M | $11M | $11M | $14M | $15M | |
| PP&E (Gross) | $8M | $11M | $11M | $11M | $11M | $11M | $11M | $12M | $14M | $14M | $14M | $14M | $16M | $17M | |
| Accum. Depreciation | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $2M | $2M | |
| Other Non-current Assets | $106.0K | $181.0K | $183.0K | $184.0K | $186.0K | $188.0K | $217.0K | $220.0K | $288.0K | $304.0K | $304.0K | $304.0K | $304.0K | $1M | |
| Total Assets | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Accounts Payable | $9M | $5M | $6M | $5M | $8M | $4M | $4M | $5M | $9M | $10M | $6M | $8M | $11M | $9M | |
| Current Liabilities | $26M | $20M | $27M | $29M | $25M | $23M | $26M | $29M | $34M | $39M | $37M | $180M | $51M | $54M | |
| Capital Leases | $6M | $18M | $18M | $17M | $17M | $17M | $17M | $18M | $18M | $18M | $19M | $19M | $20M | $20M | |
| Other Non-current Liabilities | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | $4M | $4M | $4M | |
| Total Liabilities | $83M | $88M | $96M | $98M | $85M | $83M | $89M | $91M | $92M | $99M | $98M | $245M | $119M | $117M | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $38M | |
| Total Debt | $49M | $49M | · | $51M | $41M | $42M | · | $43M | $38M | $41M | · | $39M | $38M | $38M | |
| Common Stock | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | |
| Paid-in Capital | $1.19B | $965M | $958M | $904M | $900M | $681M | $678M | $675M | $664M | $591M | $588M | $512M | $407M | $404M | |
| Retained Earnings | $-800M | $-754M | $-711M | $-683M | $-651M | $-624M | $-602M | $-584M | $-558M | $-537M | $-513M | $-561M | $-444M | $-419M | |
| AOCI | $769.0K | $985.0K | $-192.0K | $-1M | $-699.0K | $-2M | $-4M | $-2M | $2M | $-251.0K | · | · | · | · | |
| Stockholders' Equity | $387M | $212M | $247M | $219M | $249M | $55M | $72M | $89M | $109M | $54M | $75M | $-49M | $-37M | $-15M | |
| Liabilities + Equity | $470M | $300M | $343M | $317M | $333M | $138M | $160M | $180M | $200M | $153M | $173M | $196M | $82M | $102M | |
| Shares Outstanding | 325,302,280 | 287,276,885 | 285,051,648 | 273,915,373 | 272,730,060 | 205,054,570 | 204,943,306 | 204,943,306 | 201,381,450 | 187,018,275 | 186,960,193 | 186,960,193 | 64,432,637 | 63,473,349 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $6M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-40M | $-41M | $-27M | $-24M | $-20M | $-22M | $-18M | $-22M | $-22M | $-20M | $-16M | $-18M | $-19M | $-20M | |
| CapEx | $-1.0K | $24.0K | $250.0K | $108.0K | $2.0K | $378.0K | $-2.0K | $35.0K | $201.0K | $140.0K | $17.0K | $0 | $-48.0K | $4M | |
| Investing Cash Flow | $1.0K | $-3M | $-247.0K | $-48.0K | $62.0K | $-371.0K | $13.0K | $-35.0K | $-201.0K | $-140.0K | $-10.0K | $-3M | $48.0K | $-4M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $217M | $711.0K | $50M | $9M | $216M | $-52.0K | $-357.0K | $7M | $70M | $-22.0K | $-4M | $141M | $377.0K | $-370.0K | |
| Net Change in Cash | $176M | $-43M | $23M | $-15M | $196M | $-22M | $-19M | $-15M | $49M | $-20M | $-20M | $119M | $-18M | $-24M | |
| Free Cash Flow | · | $-41M | · | · | · | · | · | · | · | $-20M | · | · | · | $-24M |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| Net Margin | · | · | · | · | -1353.6% | -935.2% | · | -1427.5% | -1882.0% | -705.4% | · | -2467.1% | -1027.1% | -374.5% | |
| EBITDA Margin | · | · | · | · | -1347.1% | -930.5% | · | -1448.4% | -1915.4% | -713.3% | · | -342.4% | -976.4% | -351.9% | |
| ROA | -11.6% | -19.3% | · | -13.2% | -10.1% | -14.8% | · | -13.6% | -14.8% | -18.9% | · | -76.2% | -22.0% | -13.2% | |
| ROE | -14.7% | -31.8% | · | -21.3% | -15.0% | -39.5% | · | -128.6% | -58.3% | -123.7% | · | 616.4% | 1117.1% | -98.5% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 17.8 | 14.0 | · | 10.5 | 12.5 | 5.4 | · | 5.5 | 5.2 | 3.4 | · | 1.0 | 1.1 | 1.3 | |
| Quick Ratio | 17.5 | 13.8 | · | 10.4 | 12.3 | 5.2 | · | 5.4 | 5.1 | 3.2 | · | 0.9 | 0.9 | 1.2 | |
| Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| LT Debt / Equity | 0.1 | 0.2 | · | 0.2 | 0.2 | 0.8 | · | 0.5 | 0.3 | 0.8 | · | -0.8 | -1.0 | -2.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -788.9 | -839.0 | · | -11.0 | -16.2 | -12.1 |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.19 | $0.74 | · | $0.80 | $0.91 | $0.27 | · | $0.43 | $0.54 | $0.29 | · | $-0.26 | $-0.58 | $-0.24 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.00 | $0.01 | $0.01 | · | $0.01 | $0.00 | $0.01 | · | $0.04 | $0.04 | $0.07 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.08 | · | · | · | $-0.09 | · | · | · | $-0.32 | |
| Cash / Share | $1.40 | $0.96 | · | $1.09 | $1.15 | $0.57 | · | $0.77 | $0.86 | $0.66 | · | $0.88 | $0.70 | $1.00 | |
| EPS (TTM) | $-0.42 | $-0.38 | · | $-0.33 | $-0.34 | $-0.34 | · | $0.34 | $-0.49 | $-0.78 | · | $-2.55 | $-2.27 | $-2.74 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $5M | $7M | · | $6M | $8M | $7M | · | $10M | $13M | $14M | · | · | · | · | |
| Net Income TTM | $-150M | $-130M | · | $-100M | $-93M | $-87M | · | $-23M | $-114M | $-118M | · | $-214M | $-124M | $-133M | |
| Market Cap | $2.22B | $1.28B | · | $896M | $630M | $285M | · | $412M | $451M | $537M | · | $591M | $43M | $51M | |
| Enterprise Value | $1.81B | $1.06B | · | $649M | $358M | $211M | · | $297M | $316M | $453M | · | $465M | $36M | $25M | |
| P/E | -16.2 | -11.8 | · | -9.9 | -6.8 | -4.1 | · | 5.9 | -4.6 | -3.7 | · | -1.2 | -0.3 | -0.3 | |
| P/S | 403.9 | 171.9 | · | 141.9 | 77.8 | 39.5 | · | 41.5 | 35.0 | 37.9 | · | · | · | · | |
| P/B | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | -12.0 | -1.1 | -3.4 | |
| P / Tangible Book | 5.7 | 6.1 | · | 4.1 | 2.5 | 5.2 | · | 4.6 | 4.1 | 10.0 | · | · | · | · | |
| P / Cash Flow | · | -31.4 | · | · | · | -12.9 | · | · | · | -27.1 | · | · | · | -2.5 | |
| EV / Revenue | 329.8 | 141.4 | · | 102.9 | 44.2 | 29.2 | · | 30.0 | 24.6 | 32.0 | · | · | · | · | |
| Earnings Yield | -6.2% | -8.5% | · | -10.1% | -14.7% | -24.5% | · | 16.9% | -21.9% | -27.2% | · | -80.7% | -343.4% | -343.4% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $10M | $8M | $15M | $3M | · |
| Margin Operasi % | -1130.7% | -1097.5% | -468.8% | · | · |
| Laba Bersih | $-109M | $-89M | $-112M | $-166M | $-175M |
| EPS Dilusian | $-0.34 | $-0.36 | $-0.96 | $-3.78 | $-4.64 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | 0.2 | 0.6 | 0.5 | · | 0.4 |
| Rasio Lancar | 12.2 | 5.4 | 4.1 | · | 3.1 |
| Rasio Cepat | 12.0 | 5.3 | 3.9 | · | 2.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-94M | $-82M | $-77M | · | $-132M |
Pemilik institusional (13F) 221 pengaju · $2.1B total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
221
Nilai yang dipegang
$2.1B
Posisi baru
40
Posisi yang keluar
23
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 40 (+5 vs Kuartal sebelumnya) | 23 (-7 vs Kuartal sebelumnya) | 101 (+29 vs Kuartal sebelumnya) | 41 (-10 vs Kuartal sebelumnya) | +34.4M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| Avoro Capital Advisors LLC | $162.683.327 | 23.888.888 | 7,59% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $160.413.963 | 23.555.648 | 7,48% | Saham |
| GOLDMAN SACHS GROUP INC | $154.676.334 | 22.713.118 | 7,21% | Saham |
| BlackRock, Inc. | $140.912.023 | 20.691.927 | 6,57% | Saham |
| Vestal Point Capital, LP | $132.216.150 | 19.415.000 | 6,17% | Saham |
| MORGAN STANLEY | $112.279.731 | 16.487.479 | 5,24% | Saham |
| RTW INVESTMENTS, LP | $92.345.357 | 13.560.258 | 4,31% | Saham |
| FMR LLC | $90.820.969 | 13.336.413 | 4,24% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.979.232 | 12.478.595 | 3,96% | Saham |
| STATE STREET CORP | $77.783.275 | 11.421.920 | 3,63% | Saham |
| VANGUARD GROUP INC | $72.972.929 | 13.267.805 | 3,40% | Saham |
| Siren, L.L.C. | $67.055.203 | 9.846.579 | 3,13% | Saham |
| Octagon Capital Advisors LP | $66.010.992 | 9.693.244 | 3,08% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $44.685.322 | 6.560.394 | 2,08% | Saham |
| Polar Capital Holdings Plc | $34.847.676 | 5.117.133 | 1,63% | Saham |
| MPM BIOIMPACT LLC | $30.645.000 | 4.500.000 | 1,43% | Saham |
| D. E. Shaw & Co., Inc. | $29.954.821 | 4.398.652 | 1,40% | Saham |
| BAKER BROS. ADVISORS LP | $27.272.388 | 4.004.756 | 1,27% | Saham |
| WELLINGTON MANAGEMENT GROUP LLP | $27.073.870 | 3.975.605 | 1,26% | Saham |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $26.460.262 | 3.885.501 | 1,23% | Saham |
| GordonMD Global Investments LP | $24.501.508 | 723.185 | 1,14% | Saham |
| Casdin Capital, LLC | $22.132.500 | 3.250.000 | 1,03% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.383.461 | 3.140.009 | 1,00% | Saham |
| ADAR1 Capital Management, LLC | $20.705.573 | 3.040.466 | 0,97% | Saham |
| Pictet Asset Management Holding SA | $18.868.474 | 2.770.701 | 0,88% | Saham |
| Aberdeen Group plc | $15.847.905 | 2.327.152 | 0,74% | Saham |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $15.322.500 | 2.250.000 | 0,71% | Saham |
| NORGES BANK | $15.210.816 | 2.233.600 | 0,71% | Saham |
| NORTHERN TRUST CORP | $15.160.491 | 2.226.210 | 0,71% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $14.986.733 | 2.200.695 | 0,70% | Saham |
| MILLENNIUM MANAGEMENT LLC | $14.483.767 | 2.126.838 | 0,68% | Saham |
| ORBIMED ADVISORS LLC | $13.620.000 | 2.000.000 | 0,64% | Saham |
| RICE HALL JAMES & ASSOCIATES, LLC | $13.567.079 | 1.992.229 | 0,63% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $12.914.988 | 1.896.474 | 0,60% | Saham |
| B Group, Inc. | $12.261.786 | 1.800.556 | 0,57% | Saham |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $12.099.000 | 3.700.000 | 0,56% | Saham |
| Affinity Asset Advisors, LLC | $11.917.500 | 1.750.000 | 0,56% | Saham |
| BARCLAYS PLC | $11.104.787 | 1.630.659 | 0,52% | Saham |
| CITADEL ADVISORS LLC | $10.455.305 | 1.535.287 | 0,49% | Saham |
| HEIGHTS CAPITAL MANAGEMENT, INC | $10.215.000 | 1.500.000 | 0,48% | Saham |
| Seven Fleet Capital Management LP | $9.940.323 | 1.504.400 | 0,46% | Saham |
| Palo Alto Investors LP | $9.475.311 | 1.391.382 | 0,44% | Saham |
| BANK OF AMERICA CORP /DE/ | $9.349.074 | 1.372.845 | 0,44% | Saham |
| Granahan Investment Management, LLC | $8.888.255 | 1.305.177 | 0,41% | Saham |
| Quantum Private Wealth, LLC | $5.529.903 | 812.027 | 0,26% | Saham |
| FIRST TRUST ADVISORS LP | $5.387.860 | 791.169 | 0,25% | Saham |
| JPMORGAN CHASE & CO | $5.157.078 | 766.282 | 0,24% | Saham |
| Sands Capital Alternatives, LLC | $4.936.385 | 724.873 | 0,23% | Saham |
| Bank of New York Mellon Corp | $4.753.180 | 697.971 | 0,22% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $4.358.638 | 640.035 | 0,20% | Saham |
Aktivis & pemilik 5%+ 4 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Paul B Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, The PBM 2025 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC | 3 Juni 2025 | 9,80% | Amandemen | · | SEC |
| Paul B. Manning, The Paul B. Manning Revocable Trust dated May 10, 2000, The PBM 2023 Grantor Retained Annuity Trust, BKB Growth Investments, LLC, BKB G2 Investments, LLC ×3 pengajuan | 21 Agu 2023 | · | Pengajuan awal | · | SEC |
| Astellas Pharma Inc., Astellas US Holding, Inc., Astellas Gene Therapies, Inc. (f/k/a Audentes Therapeutics, Inc.) ×2 pengajuan | 18 Agu 2023 | · | Pengajuan awal | · | SEC |
| RA Session II, RA Session II, as Trustee of the Session 2020 Annuity Trust I, RA Session II, as Trustee of the Session 2020 Annuity Trust II | 5 Okt. 2020 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 11 orang dalam · 4 pejabat · 7 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Sean P. Nolan | Chief Executive Officer | 26 Jan. 2026 S | 2.908.257 | 0 | 2 | $-840.196 |
| Kamran Alam | CHIEF FINANCIAL OFFICER | 4 Feb. 2026 S | 1.442.131 | 0 | 3 | $-492.523 |
| Sukumar Nagendran | President and Head of R&D | 10 April 2026 M | 1.136.410 | 0 | 6 | $-4.077.375 |
| Suyash Prasad | CMO and Head of R&D | 6 Juli 2022 S | 530.589 | 0 | 0 | $0 |
| Alison S Long | Direktur | 2 Juni 2025 A | 105.843 | 0 | 0 | $0 |
| Laura Sepp-Lorenzino | Direktur | 2 Juni 2025 A | 105.843 | 0 | 0 | $0 |
| John A Stalfort III | Direktur | 2 Juni 2025 A | 1.155.224 | 0 | 0 | $0 |
| Phillip B. Donenberg | Direktur | 2 Juni 2025 A | 219.954 | 0 | 0 | $0 |
| Kathleen Reape | Direktur | 22 Juni 2023 A | · | 0 | 0 | $0 |
| Paul B Manning | Pemilik 10% | 30 Mei 2025 P | 2.841.704 | 0 | 0 | $0 |
| R.A. Session II | Pemilik 10% | 13 Juli 2023 S | 8.871.747 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 34 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IBRN · iShares Trust | 1,29% | 18.665 SH | 11 Sep. 2026 | Harian |
| BBC · ETFis Series Trust I | 0,69% | 54.433 NS | 31 Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,34% | 758.584 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,22% | 189.117 NS | 31 Juli 2026 | N-PORT |
| ESSC · Strategy Shares | 0,15% | 9.374 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 332.492 SH | 19 Agu 2026 | Harian |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,11% | 256.192 NS | 31 Juli 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 23.041 SH | 2 Okt. 2026 | Harian |
| IBB · iShares Trust | 0,10% | 2.030.172 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,10% | 257.044 SH | 19 Agu 2026 | Harian |
| IWO · iShares Trust | 0,08% | 2.238.896 SH | 11 Sep. 2026 | Harian |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,07% | 68.720 NS | 31 Juli 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,06% | 2.584 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.379.816 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,05% | 114.788 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,04% | 6.131.004 SH | 11 Sep. 2026 | Harian |
| ISCG · iShares Trust | 0,04% | 66.643 SH | 11 Sep. 2026 | Harian |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 115.014 SH | 2 Okt. 2026 | Harian |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 3.043.718 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,02% | 552.457 SH | 19 Agu 2026 | Harian |
| TEXN · iShares Trust | 0,02% | 680 SH | 11 Sep. 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 87.466 NS | 31 Juli 2026 | N-PORT |
| WSML · iShares Trust | 0,01% | 8.303 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 78.390 NS | 31 Juli 2026 | N-PORT |
| TILT · FlexShares Trust | 0,00% | 9.954 NS | 31 Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 332.286 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 70.755 SH | 11 Sep. 2026 | Harian |
| DCOR · Dimensional ETF Trust | 0,00% | 4.760 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 5.870 NS | 31 Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 3.045 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 10.179 NS | 31 Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 9.141.487 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 20.636 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 9.303 SH | 11 Sep. 2026 | Harian |
TSHA Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 18 analis
BELI
Target median
$12.00
+159,2%
6 33,3%
Beli Kuat
11 61,1%
Beli
1 5,6%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
13 analis · 2026-10-04Target rata-rata $13.00 +180,8%
← Di bawah semua target
Harga saat ini $4.63
Rendah$9.00
Rata-rata$13.00
Tinggi$19.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| STOK | $1.87B | -264.5 | 404.5% | -3.7% | -2.0% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| COAG | · | · | · | · | · | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini
Taysha Gene Therapies (TSHA) Melaporkan Hasil Keuangan untuk Q1 2026
Yahoo Finance · 4 bulan, 2 minggu lalu
Canaccord Tetap Pertahankan Peringkat Beli pada Taysha (TSHA) Setelah Sorotan Q1
Yahoo Finance · 4 bulan, 3 minggu lalu
Saham Taysha Gene Therapies (TSHA) Melonjak 343,45% dari Tingkat Setahun Lalu
Yahoo Finance · 5 bulan, 1 minggu lalu
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 11, 2026